OUTCOMES OF THE SELF-INJECTION ASSESSMENT QUESTIONNAIRE IN RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS RECEIVING GP2015 (ETANERCEPT BIOSIMILAR) IN A REAL-WORLD STUDY: FINAL RESULTS FROM COMPACT STUDY

被引:0
|
作者
Schmalzing, M. [1 ]
Askari, A. [2 ]
Sheeran, T. [3 ]
Jathanakodi, S. [4 ]
Both, C. [4 ]
Kellner, H. [5 ]
机构
[1] Wuerzburg, Univ Hosp, Dept Internal Med 2, Rheumatol Clin Immunol, Wurzburg, Germany
[2] Robert Jones & Agnes Hunt Orthoped Hosp NHS Fdn T, Rheumatol, Oswestry, Shrops, England
[3] Univ Wolverhampton, New Cross & Cannock Chase Hosp, Dept Rheumatol, Wolverhampton, England
[4] Sandoz Hexal AG, Rheumatol, Holzkirchen, Germany
[5] Hosp Neuwittelsbach, Ctr Rheumatol & Gastroenterol, Munich, Germany
关键词
Rheumatoid arthritis; Spondyloarthritis; Patient reported outcomes;
D O I
10.1136/annrheumdis-2023-eular.442
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0419
引用
收藏
页码:1397 / 1397
页数:1
相关论文
共 27 条
  • [1] Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE
    Feist, Eugen
    Baraliakos, Xenofon
    Behrens, Frank
    Thaci, Diamant
    Plenske, Anja
    Klaus, Pascal
    Meng, Thomas
    RHEUMATOLOGY AND THERAPY, 2024, 11 (02) : 331 - 348
  • [2] GO-BEYOND: a real-world study of persistence of golimumab in patients with axial spondyloarthritis and rheumatoid arthritis in Turkey
    Akar, Servet
    Kalyoncu, Umut
    Dalkilic, Ediz
    Emmungil, Hakan
    Aziz, Ayten
    Esen, Yasemin
    Koc, Tuba
    IMMUNOTHERAPY, 2021, 13 (10) : 841 - 850
  • [3] Real-World Experience with an Adalimumab Biosimilar (ABP 501) in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis in Europe: Results from the Adelphi Disease Specific Programme
    Jin, Ran
    Haughton, James M.
    Goddard, Emily J.
    Courmier, Delphine
    Radziszewski, Waldemar
    Meadows, Rachael H.
    Piercy, James
    Cohen, Stanley
    RHEUMATOLOGY AND THERAPY, 2025, : 469 - 492
  • [4] Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study
    D'Angelo, Salvatore
    Tirri, Enrico
    Giardino, Angela Maria
    Mattucci-Cerinic, Marco
    Dagna, Lorenzo
    Santo, Leonardo
    Ciccia, Francesco
    Frediani, Bruno
    Govoni, Marcello
    Pallavicini, Francesca Bobbio
    Grembiale, Rosa Daniela
    Delle Sedie, Andrea
    Mule, Rita
    Cantatore, Francesco Paolo
    Foti, Rosario
    Gremese, Elisa
    Conigliaro, Paola
    Salaffi, Fausto
    Viapiana, Ombretta
    Cauli, Alberto
    Giacomelli, Roberto
    Arcarese, Luisa
    Guggino, Giuliana
    Russo, Romualdo
    Puenpatom, Amy
    Capocotta, Domenico
    Nacci, Francesca
    Anelli, Maria Grazia
    Picerno, Valentina
    Binetti, Corrado
    Iannone, Florenzo
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
  • [5] Real-world effectiveness of golimumab in adult patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis and an inadequate response to initial TNFi therapy in Greece: the GO-BEYOND prospective, observational study
    Athanassiou, Panagiotis
    Psaltis, Dimitrios
    Georgiadis, Athanasios
    Katsifis, Gkikas
    Theodoridou, Athina
    Gazi, Souzana
    Sidiropoulos, Prodromos
    Tektonidou, Maria G. G.
    Bounas, Andreas
    Kandyli, Anna
    Vounotrypidis, Periklis
    Sakellariou, Grigorios T. T.
    Vassilopoulos, Dimitrios
    Huang, Zhiping
    Petrikkou, Evangelia
    Boumpas, Dimitrios
    RHEUMATOLOGY INTERNATIONAL, 2023, 43 (10) : 1871 - 1883
  • [6] Real-world effectiveness of golimumab in adult patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis and an inadequate response to initial TNFi therapy in Greece: the GO-BEYOND prospective, observational study
    Panagiotis Athanassiou
    Dimitrios Psaltis
    Athanasios Georgiadis
    Gkikas Katsifis
    Athina Theodoridou
    Souzana Gazi
    Prodromos Sidiropoulos
    Maria G. Tektonidou
    Andreas Bounas
    Anna Kandyli
    Periklis Vounotrypidis
    Grigorios T. Sakellariou
    Dimitrios Vassilopoulos
    Zhiping Huang
    Evangelia Petrikkou
    Dimitrios Boumpas
    Rheumatology International, 2023, 43 : 1871 - 1883
  • [7] Real-world effectiveness and retention rate of upadacitinib in patients with rheumatoid arthritis: results from a multicentre study
    Baldi, Caterina
    Gentileschi, Stefano
    Li Gobbi, Francesca
    Cazzato, Massimiliano
    Delle Sedie, Andrea
    Gaggiano, Carla
    D'Ignazio, Emilio
    Lepri, Gemma
    De Lorenzo, Chiara
    Nannini, Carlotta
    Niccoli, Laura
    Panaccione, Anna
    Di Cato, Luca
    Di Matteo, Andrea
    Picchianti-Diamanti, Andrea
    Guiducci, Serena
    Frediani, Bruno
    Benucci, Maurizio
    CLINICAL AND EXPERIMENTAL MEDICINE, 2025, 25 (01)
  • [8] Using natural language processing to explore characteristics and management of patients with axial spondyloarthritis and psoriatic arthritis treated under real-world conditions in Spain: SpAINET study
    Benavent, Diego
    Munoz-Fernandez, Santiago
    De la Morena, Isabel
    Fernandez-Nebro, Antonio
    Marin-Corral, Judith
    Rosa, Eva Castillo
    Taberna, Miren
    Sanabra, Cristina
    Sastre, Carlos
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2023, 15
  • [9] Efficacy of switching from originator etanercept to biosimilar YLB113 in real-world patients with rheumatoid arthritis: A retrospective 12 months follow-up study
    Sakane, Hideo
    Yonemoto, Yukio
    Okamura, Koichi
    Suto, Takahito
    Inoue, Makoto
    Mitomi, Hirofumi
    Tsuchida, Kosei
    Kaneko, Tetsuya
    Tamura, Yasuyuki
    Chikuda, Hirotaka
    JOURNAL OF ORTHOPAEDIC SURGERY, 2024, 32 (02)
  • [10] Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study
    Rieke Alten
    Xavier Mariette
    Hanns-Martin Lorenz
    Hubert Nüßlein
    Mauro Galeazzi
    Federico Navarro
    Melanie Chartier
    Julia Heitzmann
    Coralie Poncet
    Christiane Rauch
    Manuela Le Bars
    Clinical Rheumatology, 2019, 38 : 1413 - 1424